A Cross-sectional Study of Covid-19 Pandemic in Zhejiang Province

Sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05668052
Collaborator
(none)
500
12.1

Study Details

Study Description

Brief Summary

this study adopted a cross-sectional study, collected the medical history and symptoms of patients infected with Covid-19 through a questionnaire survey, and made statistical analysis, so as to provide better clinical guidance.

Condition or Disease Intervention/Treatment Phase
  • Other: questionnaire

Detailed Description

Recently, there has been an outbreak of covid-19 in Zhejiang Province. In order to comprehensively understand the condition of patients with covid-19 in Zhejiang Province, this study adopted a cross-sectional study, collected the medical history and symptoms of patients infected with Covid-19 through a questionnaire survey, and made statistical analysis, so as to provide better clinical guidance.

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
A Cross-sectional Study of Covid-19 Pandemic in Zhejiang Province
Anticipated Study Start Date :
Dec 27, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Outcome Measures

Primary Outcome Measures

  1. characters of patients with Covid-19 [baseline]

    this study collected the medical history and symptoms of patients infected with Covid-19 through a questionnaire survey, and made statistical analysis

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • A positive nucleic acid test for Covid-19, or a positive antigen test for novel coronavirus, no age limit.
Exclusion Criteria:
  • Unable to understand the contents of the questionnaire for various reasons

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The First Affiliated Hospital of Zhejiang Chinese Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The First Affiliated Hospital of Zhejiang Chinese Medical University
ClinicalTrials.gov Identifier:
NCT05668052
Other Study ID Numbers:
  • 20221220,F1.0
First Posted:
Dec 29, 2022
Last Update Posted:
Dec 29, 2022
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by The First Affiliated Hospital of Zhejiang Chinese Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 29, 2022